Clinical Trial

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.
Trial Details
NCT Number NCT07660406
Lead Sponsor Peking Union Medical College Hospital
Conditions Keloid
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-10-23 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-22